The relationship between a multi-specific antibody's design and its function is often non-intuitive. LabGenius's ML platform excels by exploring this complex "fitness landscape" without human bias, identifying high-performing molecules that a rational designer would deem too unconventional or "crazy."

The core philosophy behind ESMFold is that massive datasets and large transformer models can learn fundamental biological principles without needing built-in domain knowledge, applying Rich Sutton's "The Bitter Lesson" directly to bioinformatics.

An anecdote about a "wonky" BindCraft design with disconnected beta sheets, which experts predicted would fail, highlights a key trend. The resulting binder was one of the best ever produced, suggesting AI models are extracting structural principles that go beyond traditional human "protein literacy" and intuition.

The success of protein language models can be explained by Zellig Harris's 1954 linguistic theory. Just as a word's meaning is defined by its contexts, an amino acid's biological role is determined by the sequences it can appear in. The model learns this deep statistical structure, effectively learning biology.

Trained only on sequence prediction, ESM-C independently developed a hierarchical feature space mirroring decades of human scientific discovery. Its learned representations range from basic biochemical properties to complex, abstract functional concepts, all without prior biological knowledge.

ESM-C is used as a predictive "world model" rather than a direct generator. Protein design, including for complex antibodies (SCFVs), is framed as a search problem: find molecules within the model's learned space that satisfy desired criteria. This approach is achieving therapeutically relevant binding affinities.

Generate Biomedicines' AI learns the fundamental rules of protein structure and function, much like a language's grammar. This allows it to design entirely new proteins by generating novel "sentences" (sequences) that are biologically coherent and functional, rather than just mimicking existing ones found in nature.

Biohub applies mechanistic interpretability to its protein language models. By analyzing the model's internal representations—learned from both known and unknown biology—researchers can uncover emergent biological principles. This turns the model from a black box predictor into an engine for scientific discovery itself.

Resvita Bio's approach isn't about creating proteins from scratch. Instead, they use machine learning to 'read the book of life comprehensively,' analyzing how different organisms have evolved to solve the same biological problem. This allows them to synthesize nature's best solutions into an ideal therapeutic protein.